These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3887196)

  • 1. [Chymopapain allergy. Diagnostic value of a skin test before and after chemonucleolysis].
    Mayer HM; Brock M
    Neurochirurgia (Stuttg); 1985 Mar; 28(2):51-6. PubMed ID: 3887196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin testing for chymopapain allergy in chemonucleolysis.
    Mayer HM; Wehr M; Brock M; Kaden B
    Surg Neurol; 1986 Mar; 25(3):283-9. PubMed ID: 3945910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. A preliminary report.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Dolovich J; Schatz M; Zeiger R; Cogen F; Shaughnessy JJ; Chandler MJ
    Clin Orthop Relat Res; 1987 Aug; (221):202-6. PubMed ID: 3608299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence and prevention of allergic reactions following chemonucleolysis with chymopapain].
    Mayer HM
    Neurochirurgia (Stuttg); 1986 Sep; 29 Suppl 1():149-53. PubMed ID: 3491335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitization to chymopapain in patients treated with chemonucleolysis].
    García-Ortega P; Ramírez Ferreiras W; Sancho A; Urías S; Cisteró A
    Med Clin (Barc); 1991 Mar; 96(11):410-2. PubMed ID: 2046428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anesthesiologic aspects of chemonucleolysis in local anesthesia].
    Schäffer J; Piepenbrock S; Mayer HM; Brock M
    Anasth Intensivther Notfallmed; 1985 Apr; 20(2):62-4. PubMed ID: 2990249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two anaphylactic deaths after chemonucleolysis.
    DiMaio VJ
    J Forensic Sci; 1976 Jan; 21(1):187-90. PubMed ID: 129501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chymopapain allergy: case reports and identification of patients at risk for chymopapain anaphylaxis.
    Grammer LC; Ricketti AJ; Schafer MF; Patterson R
    Clin Orthop Relat Res; 1984 Sep; (188):139-43. PubMed ID: 6380859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Cogen F; Dolovich J; Schatz M; Zeiger R; Shaughnessy JJ; Gutt L
    Clin Orthop Relat Res; 1988 Sep; (234):12-5. PubMed ID: 3409565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymopapain-induced hypersensitivity following chemonucleolysis.
    Tsay YG; Jones R; Calenoff E; Sun J; Arndt L; Crispin B; McDermott D; Stern I
    Spine (Phila Pa 1976); 1984 Oct; 9(7):769-71. PubMed ID: 6390723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin tests for chymopapain allergy.
    McCulloch JA; Canham WD; Dolovich J
    Ann Allergy; 1985 Oct; 55(4):609-11. PubMed ID: 4051266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allergy to chymopapain: value of predictive tests before chemonucleolysis].
    Moneret-Vautrin DA; Benoist M; Laxenaire MC; Croizier A; Guéant JL
    Ann Fr Anesth Reanim; 1985; 4(3):313-5. PubMed ID: 3893237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemonucleolysis for relief of sciatica due to a herniated intervertebral disc.
    McCulloch JA
    Can Med Assoc J; 1981 Apr; 124(7):879-82. PubMed ID: 7011530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions to chemonucleolysis: anesthetic considerations.
    Moss J; Roizen MF
    Int Anesthesiol Clin; 1985; 23(3):119-32. PubMed ID: 2863221
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective evaluation of chymopapain sensitivity in patients undergoing chemonucleolysis.
    Bernstein DI; Gallagher JS; Ulmer A; Bernstein IL
    J Allergy Clin Immunol; 1985 Sep; 76(3):458-65. PubMed ID: 3897344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of patients at risk of allergy to chymopapain before and after chemonucleolysis. Choice of preventive medication].
    Castagnera L; Maurette P; Macouillard G; Lavignolle B
    Acta Orthop Belg; 1987; 53(2):213-20. PubMed ID: 3687407
    [No Abstract]   [Full Text] [Related]  

  • 17. Chymodiactin postmarketing surveillance. Demographic and adverse experience data in 29,075 patients.
    Agre K; Wilson RR; Brim M; McDermott DJ
    Spine (Phila Pa 1976); 1984; 9(5):479-85. PubMed ID: 6387953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for latent sensitization to chymopapain: predictive skin-prick tests in 700 candidates for chemonucleolysis.
    Moneret-Vautrin DA; Feldmann L; Kanny G; Baumann A; Roland J; Pere P
    Clin Exp Allergy; 1994 May; 24(5):471-6. PubMed ID: 8087659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between hypersensitivity to parenteral chymopapain and the presence of IgE anti-chymopapain antibody.
    Kapsalis AA; Stern IJ; Bornstein I
    Clin Exp Immunol; 1978 Jul; 33(1):150-8. PubMed ID: 709910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemonucleolysis. The treatment of lumbar intervertebral disc disease by the intradiscal injection of chymopapain.
    Watts C; Gaines R
    Mo Med; 1983 Dec; 80(12):735-7, 742. PubMed ID: 6371477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.